4.5 Article

Breast cancer management in low resource countries (LRCs): Consensus statement from the Breast Health Global Initiative

Journal

BREAST
Volume 20, Issue -, Pages S3-S11

Publisher

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.breast.2011.02.006

Keywords

Breast cancer; Low income countries; Community awareness; Treatment; Diagnosis; Palliative care

Funding

  1. Fred Hutchinson Cancer Research Center
  2. Susan G. Komen for the Cure [SG09-0605-01-BHGI]
  3. U.S. Office of International Affairs, National Cancer Institute
  4. European School of Oncology
  5. Pan American Health Organization
  6. Sheikh Mohammed Hussein Al-Amoudi Center of Excellence in Breast Cancer
  7. American Society of Clinical Oncology
  8. LIVESTRONG
  9. U.S. Centers for Disease Control and Prevention
  10. U.S. Office of Women's Health, Department of Health and Human Services
  11. U.S. Office of Science Planning and Assessment, National Cancer Institute
  12. U.S. Office of Research on Women's Health, National Institutes of Health
  13. GE Healthcare
  14. sanofi-aventis
  15. Breast Health Global Initiative (BHGI)
  16. Bayer Sherling Pharma
  17. Breast Cancer Research Foundation (BCRF)
  18. ASCO
  19. UICC
  20. ESMO
  21. RWC
  22. University of Washington
  23. Genentech
  24. AstraZeneca
  25. Genentech - Amgen
  26. Novartis - Roche

Ask authors/readers for more resources

The Breast Health Global Initiative (BHGI) brought together international breast cancer experts to discuss breast cancer in low resource countries (LRCs) and identify common concerns reviewed in this consensus statement. There continues to be a lack of public and health care professionals' awareness of the importance of early detection of breast cancer. Mastectomy continues to be the most common treatment for breast cancer; and a lack of surgeons and anesthesia services was identified as a contributing factor in delayed surgical therapy in LRCs. Where available, radiation therapy is still more likely to be used for palliation rather than for curative treatment. Tumor receptor status is often suboptimally performed due to lack of advanced pathology services and variable quality control of tissue handling and processing. Regional pathology services can be a cost-effective approach and can serve as reference, training and research centers. Limited availability of medical oncologists in LRCs often results in non-specialist providing chemotherapeutic services, which requires additional supervision and training. Palliative care is an emerging field in LRCs that requires investment in training and infrastructure development. A commitment and investment in the development of breast cancer care services by LRC governments and health authorities remains a critical need in LRCs. (C) 2011 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available